DOCM.SW climbs 8.96% to CHF6.57 on 16 Jan 2026: high volume signals renewed demand
DOCM.SW stock jumped 8.96% after hours to CHF6.57 on 16 Jan 2026 on the SIX exchange in Switzerland. The move came with 515,043 shares traded, above the average daily volume of 339,910, making DOCM.SW a clear high-volume mover in the session. We look at price drivers, fundamentals and technicals to explain why traders bought today and what to watch next.
Price action and volume
DocMorris AG (DOCM.SW) opened at CHF5.95 and printed a day low of CHF5.80 and a high of CHF6.59 before closing the regular session at CHF6.03. The after-hours push to CHF6.57 came with 515,043 shares traded, near 1.00x relative volume and well above the 50-day average of CHF5.53 per share.
Higher volume with a close above the 50-day average often reflects renewed buying interest. For DOCM.SW this followed a recent month gain of 8.17%, though the one-year change remains down 68.29%.
Earnings, fundamentals and cash metrics
DocMorris reports trailing EPS of -4.58 with a negative PE of -1.32, reflecting loss-making status. Revenue per share is 36.41 and book value per share is 16.47, giving a price-to-book of 0.37.
Liquidity looks solid with cash per share 7.89 and a current ratio of 3.25. Debt to equity sits at 0.65, showing moderate leverage for a healthcare retail group listed on SIX in Switzerland.
DOCM.SW stock technicals
Momentum indicators support the short-term bounce: RSI is 58.98, MACD histogram is 0.07, and ADX is 26.52, indicating a trending move. Bollinger Bands are 6.49/5.78/5.07 and price sits near the upper band at CHF6.57.
Support lies near the 50-day average CHF5.53 and resistance near the 200-day average CHF8.15 and the year high CHF24.90. On-chain volume indicators show positive OBV at 586,282, consistent with buying pressure.
Meyka AI grade and analyst context for DOCM.SW stock
Meyka AI rates DOCM.SW with a score of 60.18 out of 100, grade B, suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.
Independent ratings show mixed signals. Company-level metrics show strong book value and cash per share, but negative EPS and weak ROE at -29.46% increase caution among analysts.
Valuation, risks and sector context
Valuation is cheap on common multiples: P/S is 0.28 and P/B is 0.37, reflecting market skepticism despite low multiples. Enterprise value to sales is 0.43.
Key risks are persistent losses, negative net margins at -11.38%, and a year high gap at CHF24.90. In the Swiss healthcare sector, average P/E is 33.57, so DOCM.SW’s negative PE contrasts with peers and adds valuation uncertainty.
Outlook and trading strategy for high-volume moves
Short-term traders can treat the after-hours volume spike as a liquidity event and watch intraday VWAP and the 50-day level CHF5.53. Breaks above CHF6.75 on follow-through volume would validate continuation for momentum traders.
Longer-term investors should follow upcoming earnings on 2026-03-11 and monitor free cash flow per share at -2.48 and operating cash flow per share at -2.42 before adding size.
Final Thoughts
DOCM.SW stock showed a clear high-volume response after hours on 16 Jan 2026, trading 515,043 shares and rising to CHF6.57. Fundamentals are mixed: strong cash per share 7.89 and book value 16.47, but negative EPS -4.58 and ROE -29.46%. Technicals favor a short-term bounce with RSI 58.98 and ADX 26.52. Meyka AI’s forecast model projects a monthly level of CHF6.16, implying -6.24% versus today, and a quarterly target of CHF20.50, implying +212.05% upside versus CHF6.57. Forecasts are model-based projections and not guarantees. Watch volume and the upcoming earnings release on 2026-03-11 for confirmation before changing position size. This analysis is provided by Meyka AI, an AI-powered market analysis platform, and is informational only.
FAQs
What drove the DOCM.SW stock move after hours on 16 Jan 2026?
Heavy trading of 515,043 shares pushed DOCM.SW stock to CHF6.57. The move matched a rise above the 50-day average CHF5.53, attracting momentum buyers and short-term traders.
How does DocMorris AG’s valuation look for DOCM.SW stock?
DOCM.SW stock trades at P/S 0.28 and P/B 0.37, implying low market pricing versus book value. Negative EPS -4.58 and margins remain valuation headwinds.
What key levels should traders watch for DOCM.SW stock?
Watch the 50-day average at CHF5.53 as support and the 200-day average at CHF8.15 as resistance. A follow-through above CHF6.75 on heavy volume could confirm momentum.
What is Meyka AI’s view on DOCM.SW stock grade?
Meyka AI rates DOCM.SW with a score of 60.18/100, grade B, suggestion HOLD. The grade uses benchmark, sector, growth, metrics and analyst signals.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
